|
Flushing
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
One hundred and sixty-eight male Cobb 500 broiler chicks were used to evaluate the effect of two drying methods (freeze-dryer vs. forced air-oven) and two drying temperatures (40 vs. 55°C) (Exp 1), while ninety-six chicks were used to evaluate the effect of flushing and squeezing as well as marker types (titanium vs. chromium) on apparent ileal DM, N, Ca, P, and AA digestibility (Exp 2).
|
29514296 |
2018 |
|
Obesity
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
None of the CAS parameters were associated with any measures of obesity.
|
30770289 |
2019 |
|
Essential Hypertension
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, the ACE2 variant rs2074192 was associated with EH and EH with CAS ≥50%, while 3 ACE2 variants (rs4240157, rs4646155, and rs4830542) were associated with EH- and hypertension-related AF and left atrial remodeling in south Xinjiang, China.
|
30542083 |
2019 |
|
Benign Neoplasm
|
0.010 |
GeneticVariation
|
group |
BEFREE |
DNA ploidy studies were carried out on Feulgen stained smears and cytocentrifuge preparations from 35 malignant tumours and four benign neoplasms using the CAS image analyser.
|
1723634 |
1991 |
|
Acute myocardial infarction
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Aborted cardiac arrest was strongly associated with 2-year mortality in the CAS-AMI group (hazard ratios 13.5, 95% confidence interval 5.34 to 34.15, p <0.001) The incidence of MACE in CAS-AMI patients was significantly lower than in the CAA-AMI group of patients up to 2 years due to the relatively lower rate of repeat revascularization in CAS-AMI patients.
|
31547996 |
2019 |
|
Cancerophobia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This longitudinal study mapped distinct trajectories of Fear of cancer recurrence (FCR) over 12 months among patients with breast (BC) or colorectal (CRC) cancer, and examined if metacognition, indirectly via attentional bias, intrusive thoughts and avoidance (hallmarks of cognitive attentional syndrome; CAS) predicted FCR trajectory membership.
|
31663187 |
2020 |
|
Coronary Stenosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Coronary artery stenosis (CAS >50% narrowing of at least one coronary artery) was detected in 223 patients (40.5%).
|
28766048 |
2018 |
|
Malignant neoplasm of lung
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Ninety-eight Feulgen stained histologic sections from patients with breast, colon, and lung cancer were measured with the CAS 200 image analysis system (Becton Dickinson, Santa Clara, CA); they included diploid (n = 42), aneuploid (n = 46), tetraploid (n = 7), and multiploid (n = 3) examples.
|
9056741 |
1997 |
|
Triploidy syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
At the same time, the DNA content of the 46 specimens was quantified cytophotometrically using the CAS 200 image analyzer, in order to confirm or not the diagnosis of triploidy.
|
8927563 |
1995 |
|
Benign neurologic neoplasms
|
0.010 |
GeneticVariation
|
group |
BEFREE |
DNA ploidy studies were carried out on Feulgen stained smears and cytocentrifuge preparations from 35 malignant tumours and four benign neoplasms using the CAS image analyser.
|
1723634 |
1991 |
|
Carotid Atherosclerosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
All subjects were included either in the carotid atherosclerosis (AS) group or the control group according to the CAS diagnosis criteria.
|
30186852 |
2018 |
|
Carcinoma of lung
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Ninety-eight Feulgen stained histologic sections from patients with breast, colon, and lung cancer were measured with the CAS 200 image analysis system (Becton Dickinson, Santa Clara, CA); they included diploid (n = 42), aneuploid (n = 46), tetraploid (n = 7), and multiploid (n = 3) examples.
|
9056741 |
1997 |
|
Metastatic Prostate Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The orally active quinoline-3-carboxamide tasquinimod [ABR-215050; CAS number 254964-60-8), which currently is in a phase II-clinical trial in patients against metastatic prostate cancer, exhibits anti-tumor activity via inhibition of tumor angiogenesis in human and rodent tumors.
|
20470445 |
2010 |
|
Metastasis from malignant tumor of prostate
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The orally active quinoline-3-carboxamide tasquinimod [ABR-215050; CAS number 254964-60-8), which currently is in a phase II-clinical trial in patients against metastatic prostate cancer, exhibits anti-tumor activity via inhibition of tumor angiogenesis in human and rodent tumors.
|
20470445 |
2010 |
|
Primary malignant neoplasm of lung
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Ninety-eight Feulgen stained histologic sections from patients with breast, colon, and lung cancer were measured with the CAS 200 image analysis system (Becton Dickinson, Santa Clara, CA); they included diploid (n = 42), aneuploid (n = 46), tetraploid (n = 7), and multiploid (n = 3) examples.
|
9056741 |
1997 |
|
Tumor Angiogenesis
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
The orally active quinoline-3-carboxamide tasquinimod [ABR-215050; CAS number 254964-60-8), which currently is in a phase II-clinical trial in patients against metastatic prostate cancer, exhibits anti-tumor activity via inhibition of tumor angiogenesis in human and rodent tumors.
|
20470445 |
2010 |
|
Ductal Breast Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We analyzed 25 cases of archived, paraffin-embedded breast carcinoma (ductal) for Feulgen stain DNA analysis and MIB-1 immunohistochemistry using the CAS 200 Image Cytometer.
|
9142183 |
1997 |
|
Multiple Chronic Conditions
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Our objective was to determine the generalizability of the CAS-15 in a multi-institutional fashion.
|
31782808 |
2019 |
|
Colorectal Carcinoma
|
0.360 |
Biomarker
|
disease |
BEFREE |
The upregulation of karyopherin α 2 (KPNA2) and chromosome segregation 1‑like (CSE1L) in colorectal carcinoma, in addition to downregulation of chloride channel accessory 1 (CLCA1), fatty acid binding protein 1 (FABP1), sodium channel, voltage gated, type VII α subunit (SCN7A) and solute carrier family 26 (anion exchanger), member 3 (SLC26A3) was confirmed.
|
27121919 |
2016 |
|
Colorectal Carcinoma
|
0.360 |
Biomarker
|
disease |
BEFREE |
CSE1L, DIDO1 and RBM39 are located on the 20q amplicon and affect processes such as cell viability and anchorage-independent growth in colorectal cancer.
|
22711543 |
2012 |
|
Colorectal Carcinoma
|
0.360 |
Biomarker
|
disease |
BEFREE |
CSE1L was significantly increased during the transition from AD to CRC when compared with NR in a CRC tissue microarray (P = 0.01 and P < 0.001).
|
27521996 |
2016 |
|
Colorectal Carcinoma
|
0.360 |
Biomarker
|
disease |
BEFREE |
Immunohistochemistry of a colorectal cancer tissue microarray showed that CSE1L had a significantly increased level in colorectal cancer compared to normal colorectal epithelium (p < 0.001).
|
22450763 |
2012 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The combination of CTNB1, XPO2, and CAPG achieved 95% sensitivity and 96% specificity for the discrimination of these subtypes.<b>Conclusions:</b> We developed two uterine aspirate-based signatures to diagnose EC and classify tumors in the most prevalent histologic subtypes.
|
28790116 |
2017 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Thus, CAS/Crk assembly serves as a "molecular switch" for the induction of cell migration and appears to contribute to the invasive property of tumors.
|
9472046 |
1998 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In neoplastic tissue, CAS was present in 93% of the tumors, Bax in 88%, caspase-3 in 77%, and Bcl-2 in 51%.
|
11603220 |
2001 |